UBS Global Wealth Management cut the S&P 500's 2025 target to below the 6,500 mark, widely mirroring actions from other Wall ...

UBS has received regulatory approval to fully own Beijing-headquartered UBS Securities, the Swiss bank said on Friday, ...

UBS Global Wealth Management cut the S&P 500's 2025 target to below the 6,500 mark, widely mirroring actions from other Wall ...

UBS lowered the firm’s price target on Oxford Industries (OXM) to $57 from $66 and keeps a Neutral rating on the shares. Oxford has a “decent ...

UBS analyst Jay Sole lowered the firm’s price target on Nike (NKE) to $66 from $73 and keeps a Neutral rating on the shares. Nike’s Q3 report ...

UBS has reinforced its leadership in family-office services across the Middle East, leveraging its global scale, ...

There’s no financial institution quite like UBS in Latin America. It claims to be a unique player in the region, and so it is ...

(Reuters) -UBS Group AG is exploring options to relocate its headquarters if Switzerland enforces a requirement for the bank to hold an extra $25 billion in capital, Bloomberg News reported on ...

LONDON (Reuters) -UBS is considering selling part of its asset management division that is largely focused on real estate investments, two people with knowledge of the matter told Reuters ...

A three-person Finra arbitration last week hammered UBS Financial Services Inc. when it awarded $92.2 million in damages to a group of nine investors who alleged the firm engaged in a high-risk ...

Zacks Research also issued estimates for Avanos Medical’s FY2025 earnings at $1.20 EPS, Q2 2026 earnings at ... bought and sold shares of AVNS. UBS AM a distinct business unit of UBS ASSET ...

Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Analysts at Zacks Research boosted their Q2 2025 EPS estimates for ... Finally, UBS AM a distinct business unit of UBS ASSET ...